欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0478/001
药品名称Hexvix
活性成分
    • hexaminolevulinate 85.0 mg
剂型powder and solvent for solution for intravesical use
上市许可持有人Photocure ASA Oslo, Norway
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Hexvix 85mg
    • Denmark (DK)
      Hexvix
    • Belgium (BE)
    • Netherlands (NL)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      Hexvix 85 mg Pulver und Lösungsmittel zur Herstellung einer Lösung zur intravesikalen Anwendung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      HEXVIX
    • Latvia (LV)
      Hexvix 85 mg pulveris un šķīdinātājs intravezikāli lietojama šķīduma pagatavošanai
    • Lithuania (LT)
      HEXVIX 85 mg milteliai ir tirpiklis tirpalui šlapimo pūslei
    • Estonia (EE)
      HEXVIX
    • Hungary (HU)
      Hexvix 85 mg por és oldószer intravezikális oldathoz
    • Czechia (CZ)
    • Slovenia (SI)
    • United Kingdom (Northern Ireland) (XI)
许可日期2005/03/01
最近更新日期2023/11/20
药物ATC编码
    • V04CX Other diagnostic agents
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier [Article 8.3(i)]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase